Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Clin Transplant. 2013 Sep-Oct;27(5):659-65. doi: 10.1111/ctr.12188. Epub 2013 Aug 8.
Cardiac denervation following transplantation has a variable effect on heart rate (HR), and the consequence of this is not known. We examined the impact of first-year HR on five-yr outcomes after heart transplant.
We evaluated 544 heart transplant recipients from 1994 to 2008. Patients were divided into groups by mean first-year HR: group 1, HR < 90 (mean 85.0 ± 4.3); group 2, 90 ≤ HR < 110 (mean 97.8 ± 4.9); group 3, HR ≥ 110 (mean 111.5 ± 1.8). Endpoints included one-yr freedom from treated rejection, five-yr survival, five-yr freedom from cardiac allograft vasculopathy (CAV), and five-yr freedom from non-fatal major adverse cardiac events (NF-MACE).
One-yr freedom from treated rejection, five-yr survival and freedom from CAV were not significantly different between groups. Five-yr freedom from NF-MACE was significantly lower in group 3 compared with group 2, 69% vs. 91%, p < 0.01, mainly due to higher prevalence of congestive heart failure (CHF) in group 3 over five yr.
Mean first-year HR does not provide prognostic significance for one-yr freedom from treated rejection, five-yr survival or development of CAV five yr after heart transplant. These results suggest that HR post-heart transplantation does not affect long-term outcomes, but high first-year HRs may be associated with new-onset CHF.
心脏移植后去神经支配对心率(HR)有不同的影响,其后果尚不清楚。我们研究了心脏移植后第一年 HR 对五年结局的影响。
我们评估了 1994 年至 2008 年间的 544 例心脏移植受者。根据第一年平均 HR 将患者分为三组:组 1,HR<90(平均 85.0±4.3);组 2,90≤HR<110(平均 97.8±4.9);组 3,HR≥110(平均 111.5±1.8)。终点包括一年无治疗性排斥反应、五年生存率、五年无心脏移植物血管病(CAV)和五年无非致死性重大不良心脏事件(NF-MACE)。
各组之间一年无治疗性排斥反应、五年生存率和五年无 CAV 的差异无统计学意义。与组 2 相比,组 3 五年 NF-MACE 无事件生存率显著降低,分别为 69%和 91%,p<0.01,主要是由于组 3 在五年内充血性心力衰竭(CHF)的发生率较高。
第一年平均 HR 对心脏移植后一年无治疗性排斥反应、五年生存率或五年后 CAV 的发展无预后意义。这些结果表明,心脏移植后 HR 不影响长期结局,但较高的第一年 HR 可能与新发 CHF 有关。